DEVELOPMENT OF EP547: A POTENT, HIGHLY SELECTIVE MRGPRX4 INVERSE AGONIST FOR THE TREATMENT OF CHOLESTATIC AND UREMIC PRURITIS
HEPATOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined